Search tips
Search criteria 


Logo of bmcpediBioMed Centralsearchsubmit a manuscriptregisterthis articleBMC Pediatrics
BMC Pediatr. 2012; 12: 9.
Published online Jan 23, 2012. doi:  10.1186/1471-2431-12-9
PMCID: PMC3331824
The test characteristics of head circumference measurements for pathology associated with head enlargement: a retrospective cohort study
Carrie Daymont,corresponding author1,2,3,4 Moira Zabel,3,4 Chris Feudtner,3,5,6 and David M Rubin3,5,6
1Department of Pediatrics and Child Health, The University of Manitoba, Winnipeg, Manitoba, Canada
2The Manitoba Institute of Child Health, Winnipeg, Manitoba, Canada
3Department of Pediatrics, The University of Pennsylvania, Philadelphia, Pennsylvania, USA
4Children's National Medical Center, Washington DC, USA
5Center for Clinical Epidemiology and Biostatistics, The University of Pennsylvania, Philadelphia, Pennsylvania, USA
6PolicyLab, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA
corresponding authorCorresponding author.
Carrie Daymont: cdaymont/at/; Moira Zabel: moirazabel/at/; Chris Feudtner: feudtner/at/; David M Rubin: rubin/at/
Received September 28, 2011; Accepted January 23, 2012.
The test characteristics of head circumference (HC) measurement percentile criteria for the identification of previously undetected pathology associated with head enlargement in primary care are unknown.
Electronic patient records were reviewed to identify children age 3 days to 3 years with new diagnoses of intracranial expansive conditions (IEC) and metabolic and genetic conditions associated with macrocephaly (MGCM). We tested the following HC percentile threshold criteria: ever above the 95th, 97th, or 99.6th percentile and ever crossing 2, 4, or 6 increasing major percentile lines. The Centers for Disease Control and World Health Organization growth curves were used, as well as the primary care network (PCN) curves previously derived from this cohort.
Among 74,428 subjects, 85 (0.11%) had a new diagnosis of IEC (n = 56) or MGCM (n = 29), and between these 2 groups, 24 received intervention. The 99.6th percentile of the PCN curve was the only threshold with a PPV over 1% (PPV 1.8%); the sensitivity of this threshold was only 15%. Test characteristics for the 95th percentiles were: sensitivity (CDC: 46%; WHO: 55%; PCN: 40%), positive predictive value (PPV: CDC: 0.3%; WHO: 0.3%; PCN: 0.4%), and likelihood ratios positive (LR+: CDC: 2.8; WHO: 2.2; PCN: 3.9). Test characteristics for the 97th percentiles were: sensitivity (CDC: 40%; WHO: 48%; PCN: 34%), PPV (CDC: 0.4%; WHO: 0.3%; PCN: 0.6%), and LR+ (CDC: 3.6; WHO: 2.7; PCN: 5.6). Test characteristics for crossing 2 increasing major percentile lines were: sensitivity (CDC: 60%; WHO: 40%; PCN: 31%), PPV (CDC: 0.2%; WHO: 0.1%; PCN: 0.2%), and LR+ (CDC: 1.3; WHO: 1.1; PCN: 1.5).
Commonly used HC percentile thresholds had low sensitivity and low positive predictive value for diagnosing new pathology associated with head enlargement in children in a primary care network.
Articles from BMC Pediatrics are provided here courtesy of
BioMed Central